Q2 FY2026 EarningsRVTY FY26 Q2 results presented a slight beat on the top line with revenue of $729.7M vs. $703.0M expected. While GAAP EPS of $0.47 missed the $0.605 consensus due to heavy restructuring charges ($35.5M), normalized gross margins improved to 57.1% (up 260 bps YoY) aided by $16.2M in tariff refunds. Diagnostics revenue grew 5% YoY, driven by Reproductive Health, offsetting a 2% decline in Life Sciences software revenue.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Revvity(RVTY) the Revenue is 711.11 M (-1.27%), Beat estimate;the EBIT is 208.53 M (+8.72%), Beat estimate;the EPS is 0.51 (+10.87%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.71B1.27%
0.70B2.40%
+0.01B1.13%
EBITExceed expectations
0.21B8.72%
0.19B0.43%
+0.02B9.15%
EPSMiss expectations
0.5110.87%
0.60531.52%
-0.095020.65%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf